The risk for development of transfusion-dependence was highest in MDS patients with simultaneously very low Ki-67 and Hb levels and was similar to that of the Ki-67 very low/Hb mildly reduced patient group (P = 0.14) (Figure 1C). The gene discussed is MKI67; the disease is myelodysplastic syndrome.